A Randomized, Open-label Study on the Effects of Insulin Pen Devices on Glycemic Control in Children, Adolescents and Adults With Type 1 Diabetes: Novel Pen With Memory Function (HumaPen Memoir) vs. Conventional Pen Without Memory Function (HumaPen Luxura).
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2012
At a glance
- Drugs Insulin; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 01 Jun 2012 Actual patient number changed from 260 to 263 as reported by ClinicalTrials.gov.
- 15 Mar 2012 Actual end date changed from Jul 2011 to Feb 2012 as reported by European Clinical Trials Database.